DocGo (DCGO) Financials

$1.36 0.00 (0.00%)

Closing price 05/29/2025 04:00 PM Eastern

Extended Trading

$1.36 -0.01 (-0.37%)

As of 05/29/2025 07:59 PM Eastern

Annual Income Statements for DocGo

This table shows DocGo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	20	6.86	35
Consolidated Net Income / (Loss)	13	10	31
Net Income / (Loss) Continuing Operations	13	10	31
Total Pre-Tax Income	28	16	23
Total Operating Income	29	15	22
Total Gross Profit	214	195	155
Total Revenue	617	624	441
Operating Revenue	617	624	441
Total Cost of Revenue	403	429	286
Operating Cost of Revenue	403	429	286
Total Operating Expenses	185	180	133
Selling, General & Admin Expense	139	137	103
Marketing Expense	1.51	2.80	4.76
Research & Development Expense	12	11	5.38
Depreciation Expense	16	16	11
Other Special Charges / (Income)	17	13	8.78
Total Other Income / (Expense), net	-0.94	1.24	0.95
Interest & Investment Income	-2.25	1.34	0.77
Other Income / (Expense), net	1.31	-0.10	0.18
Income Tax Expense	14	6.24	-7.96
Net Income / (Loss) Attributable to Noncontrolling Interest	-6.63	3.19	-3.84
Basic Earnings per Share	$0.20	$0.07	$0.34
Weighted Average Basic Shares Outstanding	102.40M	103.51M	101.23M
Diluted Earnings per Share	$0.18	$0.06	$0.34
Weighted Average Diluted Shares Outstanding	109.42M	105.62M	102.98M
Weighted Average Basic & Diluted Shares Outstanding	101.98M	104.17M	102.51M

This table shows DocGo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-3.26	5.50	6.53	11	7.57	4.76	-2.01	-3.47	8.06	3.15
Consolidated Net Income / (Loss)	-7.65	4.55	5.86	11	7.99	4.63	1.34	-3.92	7.15	2.47
Net Income / (Loss) Continuing Operations	-7.65	4.55	5.86	11	7.99	4.63	1.34	-3.92	7.15	2.47
Total Pre-Tax Income	-6.58	9.03	9.57	16	12	9.16	0.99	-6.05	-1.98	2.87
Total Operating Income	-7.47	10	10	16	12	8.71	1.58	-6.90	0.08	4.20
Total Gross Profit	-157	139	165	67	-98	55	125	113	42	33
Total Revenue	121	139	165	192	199	187	125	113	109	104
Operating Revenue	121	139	165	192	199	187	125	113	109	104
Total Cost of Revenue	278	0.00	0.00	125	297	132	0.00	0.00	66	71
Total Operating Expenses	-150	129	155	52	-110	46	124	120	42	29
Selling, General & Admin Expense	35	29	35	40	44	34	31	29	33	22
Marketing Expense	0.40	0.38	0.39	0.34	0.20	1.61	0.69	0.31	2.41	0.09
Research & Development Expense	3.69	3.15	2.37	2.39	3.19	3.24	2.57	1.86	1.72	1.37
Depreciation Expense	3.32	4.18	4.20	4.18	4.62	4.34	3.83	3.65	3.31	3.01
Other Special Charges / (Income)	5.53	3.30	4.01	4.31	3.49	3.55	2.40	3.64	2.17	2.20
Total Other Income / (Expense), net	0.90	-1.10	-0.58	-0.15	0.52	0.45	-0.59	0.85	-2.06	-1.33
Interest & Investment Income	-1.00	-0.59	-0.58	-0.08	0.77	0.25	0.43	-0.12	-	0.09
Other Income / (Expense), net	1.53	-0.52	-0.00	0.30	0.56	0.20	-1.02	0.16	-2.52	-1.76
Income Tax Expense	1.07	4.49	3.71	5.12	4.20	4.53	-0.36	-2.13	-9.13	0.40
Net Income / (Loss) Attributable to Noncontrolling Interest	-4.38	-0.95	-0.67	-0.62	0.42	-0.13	3.35	-0.45	-0.92	-0.69
Basic Earnings per Share	($0.02)	$0.05	$0.06	$0.11	$0.07	$0.05	($0.02)	($0.03)	$0.07	$0.03
Weighted Average Basic Shares Outstanding	102.40M	102.07M	101.84M	103.82M	103.51M	103.87M	103.59M	102.58M	101.23M	98.96M
Diluted Earnings per Share	($0.03)	$0.05	$0.06	$0.10	$0.06	$0.05	($0.02)	($0.03)	$0.11	$0.03
Weighted Average Diluted Shares Outstanding	109.42M	106.29M	106.32M	108.51M	105.62M	104.99M	103.59M	102.58M	102.98M	107.40M
Weighted Average Basic & Diluted Shares Outstanding	101.98M	102.05M	102.32M	101.57M	104.17M	103.90M	103.79M	103.47M	102.51M	102.83M

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	35	-92	-15
Net Cash From Operating Activities	70	-64	29
Net Cash From Continuing Operating Activities	70	-64	29
Net Income / (Loss) Continuing Operations	13	10	31
Consolidated Net Income / (Loss)	13	10	31
Depreciation Expense	5.61	4.83	4.11
Amortization Expense	10	12	6.45
Non-Cash Adjustments To Reconcile Net Income	28	26	11
Changes in Operating Assets and Liabilities, net	14	-117	-23
Net Cash From Investing Activities	-11	-30	-38
Net Cash From Continuing Investing Activities	-11	-30	-38
Purchase of Property, Plant & Equipment	-3.83	-7.58	-3.20
Acquisitions	-2.31	-23	-35
Purchase of Investments	-5.00	-	-
Sale of Property, Plant & Equipment	0.27	0.75	0.00
Net Cash From Financing Activities	-24	1.12	-6.18
Net Cash From Continuing Financing Activities	-24	1.12	-6.18
Repayment of Debt	-40	-4.30	-3.94
Repurchase of Common Equity	-14	0.00	-3.75
Payment of Dividends	-3.14	0.00	0.00
Issuance of Debt	45	25	0.00
Issuance of Common Equity	0.00	0.00	2.06
Other Financing Activities, net	-12	-20	-0.55
Cash Interest Paid	2.14	0.85	0.76
Cash Income Taxes Paid	7.25	4.25	1.51

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-1.24	23	27	-13	4.96	-57	-3.76	-37	-15	-29
Net Cash From Operating Activities	13	31	37	-11	-5.92	-46	11	-23	-8.74	7.42
Net Cash From Continuing Operating Activities	13	31	37	-11	-5.92	-46	11	-23	-8.74	7.42
Net Income / (Loss) Continuing Operations	-7.65	4.55	5.86	11	7.99	4.63	1.34	-3.92	7.15	2.47
Consolidated Net Income / (Loss)	-7.65	4.55	5.86	11	7.99	4.63	1.34	-3.92	7.15	2.47
Depreciation Expense	1.32	1.37	1.48	1.43	0.13	1.63	1.59	1.48	1.52	1.15
Amortization Expense	2.00	2.80	2.73	2.75	4.48	2.71	2.24	2.17	1.79	1.86
Non-Cash Adjustments To Reconcile Net Income	14	4.36	4.10	5.38	10	2.17	6.42	6.79	6.23	3.72
Changes in Operating Assets and Liabilities, net	3.25	18	23	-31	-29	-57	-0.90	-30	-25	-1.78
Net Cash From Investing Activities	-5.57	-1.51	-2.09	-1.70	-2.96	-1.50	-24	-1.69	-0.65	-36
Net Cash From Continuing Investing Activities	-5.57	-1.51	-2.09	-1.70	-2.96	-1.50	-24	-1.69	-0.65	-36
Purchase of Property, Plant & Equipment	-0.89	-0.79	-1.20	-0.95	-3.22	-0.80	-1.58	-1.98	-1.20	-1.05
Acquisitions	0.23	-0.82	-0.94	-0.77	-0.21	-0.70	-22	0.17	0.55	-35
Sale of Property, Plant & Equipment	0.10	0.10	0.06	0.03	0.47	-0.00	0.16	0.12	0.00	-
Net Cash From Financing Activities	-7.86	-7.35	-8.07	-0.88	13	-8.67	8.76	-12	-6.87	-0.44
Net Cash From Continuing Financing Activities	-7.86	-7.35	-8.07	-0.88	13	-8.67	8.76	-12	-6.87	-0.44
Repayment of Debt	3.09	-1.09	-1.07	-41	-1.47	-1.06	-1.63	-0.13	-1.20	-2.44
Repurchase of Common Equity	-2.68	-1.30	-4.90	-4.88	-	-	-	0.00	-3.23	0.00
Payment of Dividends	-1.04	-1.85	-	-	-	-	-	-	-	-
Other Financing Activities, net	-7.22	-3.11	-1.84	-0.02	-11	-7.60	10	-12	-1.43	2.01
Cash Interest Paid	0.07	0.79	0.65	0.63	0.28	0.19	0.35	0.03	0.22	0.41
Cash Income Taxes Paid	0.71	5.17	0.81	0.56	0.03	-	4.18	0.04	0.59	0.16

This table presents DocGo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	456	490	393
Total Current Assets	304	339	271
Cash & Equivalents	89	59	157
Accounts Receivable	211	262	103
Prepaid Expenses	4.34	17	6.27
Plant, Property, & Equipment, net	15	17	21
Total Noncurrent Assets	136	135	101
Noncurrent Note & Lease Receivables	15	12	9.04
Goodwill	47	48	39
Intangible Assets	26	38	23
Noncurrent Deferred & Refundable Income Taxes	8.42	12	9.96
Other Noncurrent Operating Assets	39	26	19
Total Liabilities & Shareholders' Equity	456	490	393
Total Liabilities	140	185	114
Total Current Liabilities	122	170	100
Short-Term Debt	30	25	0.66
Accounts Payable	28	20	22
Accrued Expenses	50	91	32
Other Current Liabilities	14	34	42
Total Noncurrent Liabilities	19	15	14
Long-Term Debt	0.01	0.04	1.24
Other Noncurrent Operating Liabilities	19	15	13
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	315	305	279
Total Preferred & Common Equity	321	301	273
Total Common Equity	321	301	273
Common Stock	321	321	301
Retained Earnings	-1.40	-21	-29
Accumulated Other Comprehensive Income / (Loss)	1.22	1.48	0.74
Noncontrolling Interest	-5.74	4.38	5.70

This table presents DocGo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	494	488	491	420	390	408	356
Total Current Assets	328	329	335	267	234	258	252
Cash & Equivalents	89	66	41	53	109	120	170
Accounts Receivable	234	258	283	207	118	132	80
Prepaid Expenses	5.15	5.14	11	6.90	6.79	6.74	2.39
Plant, Property, & Equipment, net	15	16	16	22	22	22	18
Total Noncurrent Assets	150	143	139	131	134	127	86
Long-Term Investments	0.63	0.55	0.47	0.45	0.39	0.48	0.71
Noncurrent Note & Lease Receivables	15	14	13	8.57	8.96	9.17	9.42
Goodwill	48	48	47	48	48	48	35
Intangible Assets	35	36	37	39	38	39	21
Noncurrent Deferred & Refundable Income Taxes	17	14	12	8.91	11	-	-
Other Noncurrent Operating Assets	35	31	29	27	27	31	21
Total Liabilities & Shareholders' Equity	494	488	491	420	390	408	356
Total Liabilities	169	170	176	128	106	124	85
Total Current Liabilities	150	154	160	113	92	109	71
Short-Term Debt	30	30	30	14	19	0.65	5.71
Accounts Payable	35	31	26	8.95	6.69	19	22
Accrued Expenses	60	63	70	59	35	31	39
Other Current Liabilities	25	30	34	32	32	32	4.92
Total Noncurrent Liabilities	19	16	15	15	15	15	14
Long-Term Debt	0.02	0.03	0.03	2.04	1.58	1.27	1.46
Other Noncurrent Operating Liabilities	19	16	15	13	13	13	12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	26	0.00
Total Equity & Noncontrolling Interests	325	318	315	292	284	284	271
Total Preferred & Common Equity	325	315	311	288	280	279	264
Total Common Equity	325	315	311	288	280	279	264
Common Stock	321	317	320	316	312	310	302
Retained Earnings	1.86	-3.64	-10	-29	-34	-32	-37
Accumulated Other Comprehensive Income / (Loss)	2.31	1.38	1.34	0.81	1.39	0.98	-0.28
Noncontrolling Interest	-0.31	2.83	3.75	3.95	4.09	5.24	6.61

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-1.24%	41.72%	38.21%
EBITDA Growth	46.19%	-3.66%	18.23%
EBIT Growth	100.60%	-32.07%	7.46%
NOPAT Growth	48.77%	-68.48%	97.99%
Net Income Growth	32.96%	-67.32%	60.29%
EPS Growth	200.00%	-82.35%	36.00%
Operating Cash Flow Growth	209.52%	-322.45%	1,582.47%
Free Cash Flow Firm Growth	120.76%	-242.02%	-1,750.53%
Invested Capital Growth	-5.54%	120.48%	132.49%
Revenue Q/Q Growth	-11.28%	16.95%	-2.70%
EBITDA Q/Q Growth	-29.79%	71.22%	-39.53%
EBIT Q/Q Growth	-37.73%	367.04%	-51.15%
NOPAT Q/Q Growth	-53.68%	-38.21%	-18.71%
Net Income Q/Q Growth	-53.93%	9.18%	-29.92%
EPS Q/Q Growth	-33.33%	-45.45%	-98.18%
Operating Cash Flow Q/Q Growth	36.49%	4.20%	0.22%
Free Cash Flow Firm Q/Q Growth	52.60%	-5.77%	0.00%
Invested Capital Q/Q Growth	-3.36%	6.71%	14.13%
Profitability Metrics	-	-	-
Gross Margin	34.64%	31.30%	35.12%
EBITDA Margin	7.44%	5.03%	7.39%
Operating Margin	4.65%	2.41%	4.96%
EBIT Margin	4.86%	2.40%	5.00%
Profit (Net Income) Margin	2.17%	1.61%	6.98%
Tax Burden Percent	48.15%	61.67%	134.95%
Interest Burden Percent	92.51%	108.97%	103.51%
Effective Tax Rate	51.85%	38.33%	-34.95%
Return on Invested Capital (ROIC)	5.24%	4.71%	33.52%
ROIC Less NNEP Spread (ROIC-NNEP)	6.21%	3.91%	32.75%
Return on Net Nonoperating Assets (RNNOA)	-0.94%	-1.27%	-21.37%
Return on Equity (ROE)	4.31%	3.44%	12.15%
Cash Return on Invested Capital (CROIC)	10.94%	-70.47%	-46.17%
Operating Return on Assets (OROA)	6.34%	3.38%	6.26%
Return on Assets (ROA)	2.82%	2.27%	8.75%
Return on Common Equity (ROCE)	4.32%	3.38%	11.84%
Return on Equity Simple (ROE_SIMPLE)	4.16%	3.34%	11.25%
Net Operating Profit after Tax (NOPAT)	14	9.28	29
NOPAT Margin	2.24%	1.49%	6.69%
Net Nonoperating Expense Percent (NNEP)	-0.97%	0.80%	0.78%
Return On Investment Capital (ROIC_SIMPLE)	4.00%	2.81%	10.49%
Cost of Revenue to Revenue	65.36%	68.70%	64.88%
SG&A Expenses to Revenue	22.51%	21.97%	23.47%
R&D to Revenue	1.88%	1.74%	1.22%
Operating Expenses to Revenue	29.99%	28.89%	30.17%
Earnings before Interest and Taxes (EBIT)	30	15	22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	46	31	33
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.35	1.93	2.66
Price to Tangible Book Value (P/TBV)	1.75	2.69	3.44
Price to Revenue (P/Rev)	0.70	0.93	1.65
Price to Earnings (P/E)	21.64	84.68	21.02
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	4.62%	1.18%	4.76%
Enterprise Value to Invested Capital (EV/IC)	1.44	2.03	4.69
Enterprise Value to Revenue (EV/Rev)	0.60	0.88	1.31
Enterprise Value to EBITDA (EV/EBITDA)	8.02	17.55	17.70
Enterprise Value to EBIT (EV/EBIT)	12.26	36.85	26.20
Enterprise Value to NOPAT (EV/NOPAT)	26.62	59.34	19.57
Enterprise Value to Operating Cash Flow (EV/OCF)	5.23	0.00	19.97
Enterprise Value to Free Cash Flow (EV/FCFF)	12.76	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.10	0.08	0.01
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.15	-0.33	-0.65
Leverage Ratio	1.53	1.51	1.39
Compound Leverage Factor	1.41	1.65	1.44
Debt to Total Capital	8.70%	7.59%	0.68%
Short-Term Debt to Total Capital	8.69%	7.58%	0.24%
Long-Term Debt to Total Capital	0.00%	0.01%	0.44%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-1.66%	1.33%	2.03%
Common Equity to Total Capital	92.97%	91.08%	97.29%
Debt to EBITDA	0.65	0.80	0.06
Net Debt to EBITDA	-1.29	-1.09	-4.79
Long-Term Debt to EBITDA	0.00	0.00	0.04
Debt to NOPAT	2.17	2.70	0.06
Net Debt to NOPAT	-4.29	-3.69	-5.30
Long-Term Debt to NOPAT	0.00	0.00	0.04
Altman Z-Score	3.90	3.61	5.54
Noncontrolling Interest Sharing Ratio	-0.22%	1.72%	2.60%
Liquidity Ratios	-	-	-
Current Ratio	2.50	1.99	2.71
Quick Ratio	2.46	1.89	2.60
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	29	-139	-41
Operating Cash Flow to CapEx	1,975.92%	-939.26%	903.53%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.30	1.41	1.25
Accounts Receivable Turnover	2.61	3.42	4.86
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	38.88	32.78	25.92
Accounts Payable Turnover	16.73	20.72	14.66
Days Sales Outstanding (DSO)	140.00	106.72	75.14
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	21.82	17.62	24.90
Cash Conversion Cycle (CCC)	118.18	89.10	50.25
Capital & Investment Metrics	-	-	-
Invested Capital	256	271	123
Invested Capital Turnover	2.34	3.17	5.01
Increase / (Decrease) in Invested Capital	-15	148	70
Enterprise Value (EV)	368	551	577
Market Capitalization	433	581	727
Book Value per Share	$3.14	$2.90	$2.66
Tangible Book Value per Share	$2.43	$2.07	$2.06
Total Capital	345	330	281
Total Debt	30	25	1.90
Total Long-Term Debt	0.01	0.04	1.24
Net Debt	-59	-34	-156
Capital Expenditures (CapEx)	3.56	6.84	3.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	123	134	14
Debt-free Net Working Capital (DFNWC)	213	194	172
Net Working Capital (NWC)	183	169	171
Net Nonoperating Expense (NNE)	0.45	-0.76	-1.28
Net Nonoperating Obligations (NNO)	-59	-34	-156
Total Depreciation and Amortization (D&A)	16	16	11
Debt-free, Cash-free Net Working Capital to Revenue	20.02%	21.54%	3.24%
Debt-free Net Working Capital to Revenue	34.50%	31.04%	38.95%
Net Working Capital to Revenue	29.63%	27.03%	38.80%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.20	$0.07	$0.34
Adjusted Weighted Average Basic Shares Outstanding	102.40M	103.51M	101.23M
Adjusted Diluted Earnings per Share	$0.18	$0.06	$0.34
Adjusted Weighted Average Diluted Shares Outstanding	109.42M	105.62M	102.98M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	101.98M	104.17M	102.51M
Normalized Net Operating Profit after Tax (NOPAT)	32	17	21
Normalized NOPAT Margin	5.20%	2.78%	4.86%
Pre Tax Income Margin	4.50%	2.61%	5.17%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	23.52%	0.00%	0.00%
Augmented Payout Ratio	126.48%	0.00%	12.20%

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-39.35%	-25.66%	31.45%	69.98%	83.16%	78.83%	14.58%	-4.15%	-10.10%	21.53%
EBITDA Growth	-115.57%	4.21%	226.93%	758.07%	1,835.08%	142.73%	-68.69%	-125.29%	-96.07%	54.17%
EBIT Growth	-148.61%	8.04%	1,720.52%	339.86%	601.01%	264.88%	-95.35%	-167.21%	-111.85%	60.66%
NOPAT Growth	-168.38%	15.84%	190.14%	321.58%	13,542.14%	21.94%	-70.49%	-150.11%	-99.64%	316.95%
Net Income Growth	-195.67%	-1.83%	336.03%	370.58%	11.82%	87.73%	-88.57%	-141.81%	-64.74%	207.71%
EPS Growth	-150.00%	0.00%	400.00%	433.33%	-45.45%	66.67%	-118.18%	-133.33%	-99.40%	-25.00%
Operating Cash Flow Growth	317.73%	167.64%	246.54%	53.98%	32.26%	-718.26%	-10.31%	-226.57%	0.71%	-7.22%
Free Cash Flow Firm Growth	106.96%	95.88%	39.78%	29.08%	-100.64%	-7,785.17%	-365.28%	-338.12%	0.00%	0.00%
Invested Capital Growth	-5.54%	4.31%	44.70%	58.25%	120.48%	135.80%	233.72%	253.87%	132.49%	5.29%
Revenue Q/Q Growth	-12.87%	-15.92%	-14.13%	-3.59%	6.80%	48.66%	11.05%	3.88%	4.28%	-4.75%
EBITDA Q/Q Growth	-119.01%	-3.81%	-29.52%	20.83%	27.22%	201.76%	241.87%	-181.56%	-84.04%	-61.08%
EBIT Q/Q Growth	-161.79%	-5.15%	-37.27%	32.22%	37.34%	1,498.18%	108.26%	-1,502.86%	-200.02%	-79.62%
NOPAT Q/Q Growth	-202.56%	-17.93%	-41.95%	39.94%	73.75%	105.57%	144.33%	-8,715.74%	-98.45%	-50.26%
Net Income Q/Q Growth	-268.23%	-22.41%	-44.75%	32.65%	72.63%	244.61%	134.29%	-154.82%	189.82%	-79.02%
EPS Q/Q Growth	-160.00%	-16.67%	-40.00%	66.67%	20.00%	350.00%	33.33%	-127.27%	266.67%	-72.73%
Operating Cash Flow Q/Q Growth	-58.47%	-16.25%	448.28%	-79.76%	87.10%	-529.04%	146.25%	-164.58%	-217.75%	-37.76%
Free Cash Flow Firm Q/Q Growth	267.29%	92.77%	20.06%	27.79%	1.00%	-5.80%	5.84%	-103.46%	-3,790.53%	-103.56%
Invested Capital Q/Q Growth	-3.36%	-5.89%	-7.25%	12.21%	6.71%	30.56%	1.43%	56.01%	14.13%	84.78%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	-130.21%	100.00%	100.00%	35.03%	-49.26%	29.51%	100.00%	100.00%	38.98%	31.70%
EBITDA Margin	-2.17%	9.95%	8.70%	10.60%	8.46%	7.10%	3.50%	-2.74%	0.80%	5.23%
Operating Margin	-6.18%	7.31%	6.15%	8.26%	5.86%	4.67%	1.26%	-6.11%	0.07%	4.03%
EBIT Margin	-4.92%	6.94%	6.15%	8.42%	6.14%	4.77%	0.44%	-5.97%	-2.24%	2.34%
Profit (Net Income) Margin	-6.33%	3.28%	3.55%	5.52%	4.01%	2.48%	1.07%	-3.47%	6.57%	2.36%
Tax Burden Percent	116.30%	50.31%	61.23%	67.44%	65.54%	50.57%	135.92%	64.79%	-361.64%	85.99%
Interest Burden Percent	110.58%	93.89%	94.31%	97.21%	99.71%	102.82%	177.40%	89.71%	80.97%	117.52%
Effective Tax Rate	0.00%	49.69%	38.77%	32.56%	34.46%	49.44%	-35.92%	0.00%	0.00%	14.01%
Return on Invested Capital (ROIC)	-10.13%	9.85%	11.76%	15.84%	12.17%	6.97%	6.10%	-15.15%	0.26%	14.93%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.96%	10.99%	12.33%	16.03%	11.81%	6.74%	6.66%	-15.81%	-4.04%	16.33%
Return on Net Nonoperating Assets (RNNOA)	0.75%	-1.74%	-2.58%	-2.78%	-3.85%	-2.41%	-3.53%	8.39%	2.63%	-7.14%
Return on Equity (ROE)	-9.38%	8.11%	9.18%	13.06%	8.33%	4.56%	2.57%	-6.76%	2.89%	7.79%
Cash Return on Invested Capital (CROIC)	10.94%	7.28%	-24.38%	-35.25%	-70.47%	-72.57%	-108.35%	-101.95%	-46.17%	0.00%
Operating Return on Assets (OROA)	-6.41%	10.55%	10.40%	13.19%	8.67%	6.57%	0.56%	-7.09%	-2.81%	4.50%
Return on Assets (ROA)	-8.25%	4.99%	6.01%	8.65%	5.67%	3.42%	1.34%	-4.12%	8.24%	4.54%
Return on Common Equity (ROCE)	-9.41%	8.06%	9.08%	12.86%	8.18%	4.48%	2.51%	-6.58%	2.82%	5.25%
Return on Equity Simple (ROE_SIMPLE)	0.00%	8.92%	9.23%	7.89%	0.00%	3.20%	2.52%	6.26%	0.00%	16.60%
Net Operating Profit after Tax (NOPAT)	-5.23	5.10	6.21	11	7.65	4.40	2.14	-4.83	0.06	3.61
NOPAT Margin	-4.33%	3.68%	3.77%	5.57%	3.84%	2.36%	1.71%	-4.28%	0.05%	3.46%
Net Nonoperating Expense Percent (NNEP)	-5.17%	-1.14%	-0.57%	-0.20%	0.36%	0.23%	-0.56%	0.66%	4.30%	-1.40%
Return On Investment Capital (ROIC_SIMPLE)	-1.52%	-	-	-	2.32%	-	-	-	0.02%	-
Cost of Revenue to Revenue	230.21%	0.00%	0.00%	64.98%	149.26%	70.49%	0.00%	0.00%	61.02%	68.30%
SG&A Expenses to Revenue	29.00%	20.76%	21.07%	20.92%	21.84%	18.02%	24.54%	25.86%	30.08%	21.27%
R&D to Revenue	3.05%	2.27%	1.44%	1.24%	1.60%	1.73%	2.05%	1.65%	1.58%	1.32%
Operating Expenses to Revenue	-124.15%	92.69%	93.85%	26.84%	-55.12%	24.84%	98.74%	106.11%	38.91%	27.67%
Earnings before Interest and Taxes (EBIT)	-5.95	9.62	10	16	12	8.91	0.56	-6.74	-2.44	2.44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2.62	14	14	20	17	13	4.39	-3.09	0.87	5.46
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.04	1.00	1.35	1.93	1.92	3.47	3.18	2.66	3.79
Price to Tangible Book Value (P/TBV)	1.75	1.40	1.35	1.85	2.69	2.75	5.00	4.62	3.44	4.79
Price to Revenue (P/Rev)	0.70	0.49	0.42	0.60	0.93	1.04	2.15	2.04	1.65	2.21
Price to Earnings (P/E)	21.64	11.02	10.43	19.48	84.68	75.23	168.85	43.28	21.02	20.01
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.62%	9.07%	9.59%	5.13%	1.18%	1.33%	0.59%	2.31%	4.76%	5.00%
Enterprise Value to Invested Capital (EV/IC)	1.44	1.05	1.00	1.36	2.03	2.05	4.55	4.03	4.69	7.85
Enterprise Value to Revenue (EV/Rev)	0.60	0.40	0.38	0.59	0.88	0.97	1.96	1.78	1.31	1.87
Enterprise Value to EBITDA (EV/EBITDA)	8.02	4.27	4.32	7.51	17.55	28.34	83.87	38.34	17.70	15.70
Enterprise Value to EBIT (EV/EBIT)	12.26	5.80	5.90	10.88	36.85	162.27	0.00	94.79	26.20	18.77
Enterprise Value to NOPAT (EV/NOPAT)	26.62	9.37	9.68	16.86	59.34	34.58	0.00	63.43	19.57	23.33
Enterprise Value to Operating Cash Flow (EV/OCF)	5.23	5.42	0.00	0.00	0.00	0.00	0.00	0.00	19.97	29.36
Enterprise Value to Free Cash Flow (EV/FCFF)	12.76	14.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.10	0.09	0.09	0.10	0.08	0.05	0.07	0.01	0.01	0.03
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.01
Financial Leverage	-0.15	-0.16	-0.21	-0.17	-0.33	-0.36	-0.53	-0.53	-0.65	-0.44
Leverage Ratio	1.53	1.48	1.46	1.50	1.51	1.38	1.34	1.40	1.39	1.26
Compound Leverage Factor	1.69	1.39	1.38	1.46	1.51	1.42	2.38	1.25	1.12	1.48
Debt to Total Capital	8.70%	8.47%	8.63%	8.71%	7.59%	5.12%	6.64%	0.67%	0.68%	2.58%
Short-Term Debt to Total Capital	8.69%	8.46%	8.63%	8.70%	7.58%	4.46%	6.12%	0.23%	0.24%	2.05%
Long-Term Debt to Total Capital	0.00%	0.01%	0.01%	0.01%	0.01%	0.67%	0.52%	0.45%	0.44%	0.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-1.66%	-0.09%	0.81%	1.09%	1.33%	1.29%	1.34%	1.83%	2.03%	2.38%
Common Equity to Total Capital	92.97%	91.62%	90.55%	90.20%	91.08%	93.59%	92.02%	97.49%	97.29%	95.04%
Debt to EBITDA	0.65	0.46	0.46	0.55	0.80	0.86	1.91	0.10	0.06	0.13
Net Debt to EBITDA	-1.29	-0.92	-0.56	-0.21	-1.09	-2.05	-8.48	-5.88	-4.79	-3.03
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.11	0.15	0.06	0.04	0.03
Debt to NOPAT	2.17	1.01	1.04	1.23	2.70	1.05	-27.52	0.16	0.06	0.20
Net Debt to NOPAT	-4.29	-2.01	-1.26	-0.48	-3.69	-2.50	121.91	-9.73	-5.30	-4.50
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.14	-2.16	0.10	0.04	0.04
Altman Z-Score	3.64	3.12	3.12	3.38	3.59	4.27	6.95	5.65	5.33	8.83
Noncontrolling Interest Sharing Ratio	-0.22%	0.59%	1.15%	1.50%	1.72%	1.88%	2.12%	2.58%	2.60%	32.59%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.50	2.19	2.13	2.09	1.99	2.36	2.56	2.37	2.71	3.54
Quick Ratio	2.46	2.15	2.10	2.03	1.89	2.30	2.48	2.31	2.60	3.51
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	9.77	-5.84	-81	-101	-140	-142	-134	-142	-70	-1.80
Operating Cash Flow to CapEx	1,616.12%	4,495.30%	3,235.64%	-1,148.13%	-215.16%	-5,704.99%	751.05%	-1,243.80%	-727.49%	705.04%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-273.66	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-28.83	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-31.34	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.30	1.52	1.69	1.57	1.41	1.38	1.25	1.19	1.25	1.92
Accounts Receivable Turnover	2.61	3.15	3.95	3.39	3.42	3.72	4.73	4.19	4.86	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	38.88	37.43	39.16	36.98	32.78	27.08	26.43	25.36	25.92	0.00
Accounts Payable Turnover	16.73	19.15	29.54	24.80	20.72	12.80	13.56	11.69	14.66	26.36
Days Sales Outstanding (DSO)	140.00	115.82	92.38	107.61	106.72	98.23	77.09	87.04	75.14	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	21.82	19.06	12.36	14.72	17.62	28.51	26.92	31.23	24.90	13.85
Cash Conversion Cycle (CCC)	118.18	96.76	80.02	92.89	89.10	69.72	50.17	55.81	50.25	-13.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	256	265	281	303	271	254	194	192	123	108
Invested Capital Turnover	2.34	2.68	3.12	2.84	3.17	2.95	3.57	3.54	5.01	4.31
Increase / (Decrease) in Invested Capital	-15	11	87	112	148	146	136	138	70	5.41
Enterprise Value (EV)	368	279	280	412	551	519	884	773	577	846
Market Capitalization	433	340	314	420	581	553	970	887	727	1,002
Book Value per Share	$3.14	$3.18	$3.10	$3.00	$2.90	$2.77	$2.70	$2.72	$2.66	$2.62
Tangible Book Value per Share	$2.43	$2.37	$2.28	$2.19	$2.07	$1.94	$1.87	$1.87	$2.06	$2.07
Total Capital	345	355	348	345	330	307	304	286	281	278
Total Debt	30	30	30	30	25	16	20	1.92	1.90	7.16
Total Long-Term Debt	0.01	0.02	0.03	0.03	0.04	2.04	1.58	1.27	1.24	1.46
Net Debt	-59	-60	-37	-12	-34	-38	-89	-119	-156	-163
Capital Expenditures (CapEx)	0.80	0.69	1.15	0.93	2.75	0.80	1.42	1.86	1.20	1.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)	123	119	139	164	134	115	52	30	14	17
Debt-free Net Working Capital (DFNWC)	213	208	205	205	194	168	161	150	172	187
Net Working Capital (NWC)	183	178	175	175	169	154	143	149	171	181
Net Nonoperating Expense (NNE)	2.42	0.55	0.36	0.10	-0.34	-0.23	0.80	-0.91	-7.09	1.14
Net Nonoperating Obligations (NNO)	-59	-60	-37	-12	-34	-38	-89	-92	-156	-163
Total Depreciation and Amortization (D&A)	3.32	4.18	4.20	4.18	4.62	4.34	3.83	3.65	3.31	3.01
Debt-free, Cash-free Net Working Capital to Revenue	20.02%	17.07%	18.65%	23.28%	21.54%	21.52%	11.54%	6.89%	3.24%	3.75%
Debt-free Net Working Capital to Revenue	34.50%	29.95%	27.55%	29.15%	31.04%	31.43%	35.71%	34.45%	38.95%	41.21%
Net Working Capital to Revenue	29.63%	25.63%	23.50%	24.88%	27.03%	28.86%	31.60%	34.30%	38.80%	39.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.02)	$0.05	$0.06	$0.11	$0.07	$0.05	($0.02)	($0.03)	$0.07	$0.03
Adjusted Weighted Average Basic Shares Outstanding	102.40M	102.07M	101.84M	103.82M	103.51M	103.87M	103.59M	102.58M	101.23M	98.96M
Adjusted Diluted Earnings per Share	($0.03)	$0.05	$0.06	$0.10	$0.06	$0.05	($0.02)	($0.03)	$0.11	$0.03
Adjusted Weighted Average Diluted Shares Outstanding	109.42M	106.29M	106.32M	108.51M	105.62M	104.99M	103.59M	102.58M	102.98M	107.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	101.98M	102.05M	102.32M	101.57M	104.17M	103.90M	103.79M	103.47M	102.51M	102.83M
Normalized Net Operating Profit after Tax (NOPAT)	-1.36	6.76	8.67	14	9.94	6.20	2.79	-2.28	1.58	5.50
Normalized NOPAT Margin	-1.13%	4.87%	5.26%	7.09%	4.99%	3.32%	2.22%	-2.02%	1.45%	5.28%
Pre Tax Income Margin	-5.44%	6.51%	5.80%	8.19%	6.12%	4.91%	0.79%	-5.35%	-1.82%	2.75%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	43.83	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	29.01	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	41.32	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	26.50	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	126.48%	38.20%	33.63%	19.85%	0.00%	35.14%	45.94%	21.38%	12.20%	1.18%

Frequently Asked Questions About DocGo's Financials

When does DocGo's financial year end?

According to the most recent income statement we have on file, DocGo's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has DocGo's net income changed over the last 2 years?

DocGo's net income appears to be on a downward trend, with a most recent value of $13.36 million in 2024, falling from $30.74 million in 2022. The previous period was $10.05 million in 2023. See where experts think DocGo is headed by visiting DocGo's forecast page.

What is DocGo's operating income?

DocGo's total operating income in 2024 was $28.69 million, based on the following breakdown:

Total Gross Profit: $213.57 million
Total Operating Expenses: $184.89 million

How has DocGo revenue changed over the last 2 years?

Over the last 2 years, DocGo's total revenue changed from $440.52 million in 2022 to $616.56 million in 2024, a change of 40.0%.

How much debt does DocGo have?

DocGo's total liabilities were at $140.44 million at the end of 2024, a 24.2% decrease from 2023, and a 22.8% increase since 2022.

How much cash does DocGo have?

In the past 2 years, DocGo's cash and equivalents has ranged from $59.29 million in 2023 to $157.34 million in 2022, and is currently $89.24 million as of their latest financial filing in 2024.

How has DocGo's book value per share changed over the last 2 years?

Over the last 2 years, DocGo's book value per share changed from 2.66 in 2022 to 3.14 in 2024, a change of 18.3%.

Related Companies

This page (NASDAQ:DCGO) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DocGo (DCGO) Financials

Frequently Asked Questions About DocGo's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DocGo (DCGO) Financials

Annual Income Statements for DocGo

Quarterly Income Statements for DocGo

Annual Cash Flow Statements for DocGo

Quarterly Cash Flow Statements for DocGo

Annual Balance Sheets for DocGo

Quarterly Balance Sheets for DocGo

Annual Metrics And Ratios for DocGo

Quarterly Metrics And Ratios for DocGo

Frequently Asked Questions About DocGo's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools